tiprankstipranks
Trending News
More News >
Evofem Biosciences (EVFM)
OTHER OTC:EVFM
US Market
Advertisement

Evofem Biosciences (EVFM) Income Statement

Compare
1,214 Followers

Evofem Biosciences Income Statement

Last quarter (Q2 2025), Evofem Biosciences's total revenue was $4.83M, an increase of 15.99% from the same quarter last year. In Q2, Evofem Biosciences's net income was $-1.78M. See Evofem Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 19.36M$ 18.22M$ 16.84M$ 8.24M$ 446.00K
Gross Profit
$ 15.53M$ 11.71M$ 12.42M$ 4.19M$ -1.20M
Operating Expenses
$ 23.20M$ 29.55M$ 96.55M$ 170.99M$ 102.42M
Depreciation and Amortization
$ 756.00K$ 1.78M$ 2.05M$ 1.02M$ 1.18M
EBITDA
$ -6.92M$ -16.07M$ -82.08M$ -165.78M$ -141.12M
Operating Income
$ -7.68M$ -17.85M$ -84.12M$ -166.80M$ -103.62M
Other Income/Expenses
$ -1.18M$ 70.84M$ 7.47M$ -38.37M$ -38.68M
Pretax Income
$ -8.86M$ 53.00M$ -76.65M$ -205.18M$ -142.31M
Net Income
$ -8.86M$ 52.98M$ -76.70M$ -205.19M$ -142.31M
Per Share Metrics
Basic EPS
$ -0.09$ 10.36$ -164.59$ -2.96K$ -3.97K
Diluted EPS
$ -0.09$ 0.05$ -164.59$ -2.96K$ -3.97K
Weighted Average Shares Outstanding
96.46M 4.83M 465.98K 69.82K 35.82K
Weighted Average Shares Outstanding (Diluted)
96.46M 984.04M 465.98K 69.82K 35.82K
Currency in USD

Evofem Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis